Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About NanoViricides Inc (NNVC)

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George Soros hold the necessary resources and abilities to conduct an extensive stock analysis on small-cap stocks, which enable them to make millions of dollars by identifying potential winners within the small-cap galaxy of stocks. This represents the main reason why Insider Monkey takes notice of the hedge fund activity in these overlooked stocks.

NanoViricides Inc (NYSEMKT:NNVC) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 4 hedge funds’ portfolios at the end of September. At the end of this article we will also compare NNVC to other stocks including TearLab Corporation (NASDAQ:TEAR), Datawatch Corporation (NASDAQ:DWCH), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to get a better sense of its popularity.

Follow Nanoviricides Inc. (NYSEMKT:NNVC)
Trade (NYSEMKT:NNVC) Now!

Keeping this in mind, we’re going to analyze the recent action encompassing NanoViricides Inc (NYSEMKT:NNVC).

Hedge fund activity in NanoViricides Inc (NYSEMKT:NNVC)

Of the funds tracked by Insider Monkey, Millennium Management, managed by Israel Englander, holds the most valuable position in NanoViricides Inc (NYSEMKT:NNVC). Millennium Management has a $0.2 million position in the stock, comprising less than 0.1% of its 13F portfolio. On Millennium Management’s heels is Renaissance Technologies, led by Jim Simons, holding a $0.1 million position; less than 0.1% of its 13F portfolio is allocated to the company. Remaining members of the smart money that hold long positions include D. E. Shaw’s D E Shaw, and Ken Griffin’s Citadel Investment Group.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...